Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.


Chiong E., Murphy D. G., Akaza H., Buchan N. C., Chung B. H., Kanesvaran R., ...Daha Fazla

BJU international, cilt.123, sa.1, ss.22-34, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 123 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1111/bju.14489
  • Dergi Adı: BJU international
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.22-34
  • Anahtar Kelimeler: advanced prostate cancer, castration-naive prostate cancer, castration-resistant prostate cancer, high-risk localised prostate cancer, oligometastatic prostate cancer, cost and access to treatment, ACETATE PLUS PREDNISONE, POST-HOC ANALYSIS, ABIRATERONE ACETATE, CHEMOTHERAPY-NAIVE, DOUBLE-BLIND, RADICAL PROSTATECTOMY, SURVIVAL ANALYSIS, PREVAIL TRIAL, PHASE-II, CASTRATION
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

ObjectiveThe Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2018) brought together 20 experts from 15 APAC countries to discuss the real-world application of consensus statements from the second APCCC held in St Gallen in 2017 (APCCC 2017).